# Executive Summary: Swin Complementary Model Design Analysis

**Date:** 2026-02-10  
**Analysis Type:** Deep, Critical Analysis of Current Swin Model for Designing Complementary Second Swin  
**Goal:** Design Swin-2 that provides non-redundant signal and significantly improves ensemble performance

---

## Critical Findings

### Current Swin (Swin-1) Performance

**Strengths:**
- ✅ **Excellent Precision:** 0.9874 (only 2 FP out of 75 LGG)
- ✅ **Strong AUC:** 0.9065 (good ranking quality)
- ✅ **High LGG Accuracy:** 97.33% (excellent at identifying LGG)
- ✅ **Low Redundancy:** Correlation with ResNet=0.25, with MIL=0.15
- ✅ **Unique Signal:** 66 cases correct only by Swin (strong complementarity)

**Critical Weaknesses:**
- ❌ **Poor Recall:** 0.7476 (53 FN out of 210 HGG)
- ❌ **FN is Primary Issue:** 53 false negatives vs only 2 false positives
- ❌ **Low Confidence on FN:** Mean prob 0.1386 ± 0.1375 (very uncertain)
- ❌ **Inconsistent Across Folds:** FN std=3.83 (Fold 4 has 18 FN vs Fold 1 has 7)

**Key Insight:** Swin-1 excels at clear patterns but **fails on subtle HGG cases** (small tumors, diffuse patterns, low contrast).

---

## Error Pattern Analysis

### False Negatives (53 cases)
- **Mean Probability:** 0.1386 ± 0.1375
- **Distribution:** Very low confidence (near 0), suggesting model is genuinely uncertain
- **Pattern:** Likely small tumors, diffuse patterns, or low-contrast regions
- **Fold Distribution:** Inconsistent (Fold 4: 18, Fold 1: 7) - suggests some folds have harder cases

### False Positives (2 cases)
- **Mean Probability:** 0.9852 ± 0.0202
- **Pattern:** Overconfident on LGG (very rare, only 2 cases)
- **Not a priority:** FP is already excellent

---

## Redundancy Analysis

| Model Pair | Correlation | Agreement | Complementarity |
|------------|-------------|-----------|-----------------|
| Swin-ResNet | 0.2535 | 58.6% | **High** (low correlation) |
| Swin-MIL | 0.1470 | 55.8% | **Very High** (very low correlation) |
| ResNet-MIL | 0.0696 | 97.2% | **Very High** (almost independent) |

**Key Finding:** Swin-1 has **strong complementarity** with existing models. Swin-2 should maintain this (correlation < 0.7 with Swin-1).

---

## Proposed Swin-2 Design

### Architectural Changes (Priority Order)

**Priority 1: High ROI, Low Risk**
1. **Patch Size: 1** (instead of 2) - Captures fine details for small tumors
2. **Focal Loss** (γ=2.0, α=0.25) - Focuses on hard examples (FN cases)
3. **Hard Example Mining** - Oversample Swin-1 FN cases during training

**Priority 2: Moderate ROI, Moderate Risk**
4. **Window Size: 4** (instead of 7) - Local attention for subtle patterns
5. **Class Weighting** (pos_weight=2.0-3.0) - Penalize FN more
6. **Stronger Augmentation** - Simulate small/diffuse tumors

**Priority 3: Lower ROI, Higher Risk**
7. **Resolution: 160³** (instead of 128³) - Better spatial detail, but risk of overfitting
8. **Deeper Network** ([3,3,3,3] instead of [2,2,2,2]) - More capacity, but risk of overfitting
9. **Larger Feature Size** (64 instead of 48) - More parameters, but risk of overfitting

---

## Feasibility Assessment

### Current vs Target Metrics

| Metric | Current | Target | Improvement Needed | Realistic? |
|--------|---------|--------|-------------------|------------|
| **FN** | 53 | < 5 | **-48 (90% reduction)** | ⚠️ **Extremely Challenging** |
| **FP** | 2 | < 5 | +3 | ✅ Easy (already better) |
| **Recall** | 0.7476 | > 0.95 | +0.2024 | ⚠️ **Very Challenging** |
| **Precision** | 0.9874 | > 0.95 | -0.0374 | ✅ Easy (already better) |
| **AUC** | 0.9065 | > 0.85 | Maintain | ✅ Easy (already better) |

### Theoretical Limits
- **Minimum Recall with FN=5:** 0.9762 (theoretically possible)
- **Minimum Precision with FP=5:** 0.9767 (theoretically possible)
- **Theoretically Possible:** ✅ Yes
- **Practical Likelihood:** ⚠️ **MODERATE** (requires near-perfect model)

### Critical Constraints
1. **Dataset Size:** 285 samples is **very small** for a larger model
2. **Overfitting Risk:** HIGH (deeper/larger model on small dataset)
3. **Improvement Magnitude:** 90% FN reduction is **extremely ambitious**

---

## GO/NO-GO Decision

### Revised Decision: **CONDITIONAL_GO**

**Reasoning:**
1. ✅ Theoretically possible (min recall 0.9762 > target 0.95)
2. ✅ High complementarity potential (Swin-1 has 66 unique correct cases)
3. ⚠️ Very challenging (90% FN reduction)
4. ⚠️ High overfitting risk (285 samples, larger model)
5. ✅ Conservative approach (Priority 1 only) is low-risk

**Recommendation:**
- **Phase 1 (GO):** Implement Priority 1 changes only (patch size=1, Focal Loss, hard example mining)
- **Phase 2 (CONDITIONAL):** If Phase 1 succeeds (FN < 40), proceed to Priority 2
- **Phase 3 (NO-GO):** Do NOT proceed to Priority 3 unless Phase 2 shows clear benefit

---

## Expected Impact

### Realistic Expectations (Phase 1 Only)
- **FN Reduction:** 53 → 30-40 (moderate improvement, 25-43% reduction)
- **Recall Improvement:** 0.75 → 0.81-0.86 (moderate improvement)
- **Complementarity:** Correlation with Swin-1 < 0.7 (maintains diversity)
- **AUC:** Maintain > 0.85 (preserves ranking quality)

### Optimistic Expectations (All Phases)
- **FN Reduction:** 53 → 15-25 (significant improvement, 53-72% reduction)
- **Recall Improvement:** 0.75 → 0.88-0.93 (significant improvement)
- **Target Achievement:** **Unlikely** (FN < 5 requires 90% reduction)

---

## Validation Signals

**Must monitor ALL of the following:**

1. **Correlation with Swin-1 < 0.7** - Ensures complementarity
2. **FN Reduction ≥ 30%** - Meaningful improvement
3. **AUC > 0.85** - Maintains ranking quality
4. **Train/Val AUC Gap < 0.10** - No severe overfitting
5. **FN Std Across Folds < 5** - Stable performance

**If ANY criterion fails → STOP and reconsider approach**

---

## Risks and Mitigation

| Risk | Likelihood | Impact | Mitigation |
|------|-----------|--------|------------|
| **Overfitting** | HIGH | CRITICAL | Strong regularization, early stopping, monitor train/val gap |
| **Redundancy** | MODERATE | HIGH | Monitor correlation, ensure < 0.7 |
| **Data Insufficiency** | HIGH | CRITICAL | Start with conservative changes (Priority 1 only) |
| **FN Reduction Failure** | MODERATE | HIGH | Hard example mining may not be enough if data is insufficient |

---

## Final Recommendations

### ✅ DO (Priority 1 - Recommended)
1. **Implement smaller patch size (1)** - Highest ROI, lowest risk
2. **Use Focal Loss** - Explicitly targets FN cases
3. **Oversample Swin-1 FN cases** - Hard example mining
4. **Validate on single fold first** - Before full 5-fold training
5. **Monitor all validation signals** - Stop if any fail

### ⚠️ CONDITIONAL (Priority 2 - If Phase 1 Succeeds)
1. **Smaller window size (4)** - Local attention
2. **Class weighting** - Penalize FN more
3. **Stronger augmentation** - Simulate small tumors

### ❌ DON'T (Priority 3 - High Risk)
1. **Higher resolution (160³)** - Too risky on 285 samples
2. **Deeper network** - Too risky on 285 samples
3. **Larger feature size** - Too risky on 285 samples

---

## Conclusion

**Current State:**
- Swin-1 is **strong but has critical weakness** (53 FN, recall 0.75)
- **High complementarity potential** (66 unique correct cases)
- **Theoretically possible** to achieve targets, but **extremely challenging**

**Recommended Approach:**
- **Start conservative** (Priority 1 only)
- **Validate rigorously** (all 5 validation signals)
- **Proceed incrementally** (Phase 1 → Phase 2 → Phase 3)
- **Be realistic** (90% FN reduction is unlikely, aim for 30-50% improvement)

**Expected Outcome:**
- **Realistic:** FN 53 → 30-40 (moderate improvement)
- **Optimistic:** FN 53 → 15-25 (significant improvement)
- **Target (FN < 5):** Unlikely without more data or different approach

---

**Decision: CONDITIONAL_GO**  
**Next Step: Implement Phase 1 (Priority 1 changes only), validate on single fold**

---

*For detailed analysis, see:*
- `swin_complementary_analysis_report.md` - Full analysis
- `swin_complementary_analysis_report.json` - Machine-readable results
- `SWIN_COMPARISON_TABLE.md` - Detailed comparison table
- `swin_analysis_plots.png` - Visualizations

